{
    "title": "New Members of the White House Coronavirus Task Force Announced – The White House",
    "link": "https://trumpwhitehouse.archives.gov/briefings-statements/new-members-white-house-coronavirus-task-force-announced/",
    "created_at": "2020-05-15T00:00:00",
    "content": "\n\t\t\t\tStatements & Releases\t\t\t\n\n\t\tHealthcare\t\n\nIssued on:\nMay 15, 2020\nDr. Francis Collins, Director of the National Institutes of HealthDr. Peter Marks, FDA Director of the Center for Biologics Evaluation and ResearchThomas Engels, Administrator of the Health Resources and Services AdministrationThe Task Force continues to review data that indicates positive signs that Americans’ efforts helped slow the spread of COVID-19. The New Orleans, New York City, and Detroit Metropolitan areas all experienced between 70 – 90 percent reductions in confirmed cases (on a 7-day rolling average basis).The response has been phased and deliberate. In the first two phases of the Task Force’s response effort to COVID-19, President Trump and Vice President Pence focused on delaying the arrival of the virus, testing, supply allocation and distribution, and mitigating the spread of the disease.Early in the response effort, the White House focused on containing the virus. The White House acted early when President Trump issued an Executive Order restricting travel from China. As a result, countless American lives were saved.Since Vice President Pence was tapped by President Trump to lead the White House response to the Coronavirus pandemic, the Task Force focused their efforts on expanding testing, supplying PPE, and mitigation efforts.Key accomplishments from the White House response in phase two include, but are not limited to:",
    "president": null
}